With a goal of improving the health of Oregonians, Oregon Health & Science University and Moda Health Plan, Inc. have signed a nonbinding letter of intent to create a joint board and provide OHSU an optin to acquire a 25 percent equity position in Moda Health by converting a $50 million surplus note.
Oregon Health & Science University and Salem Health have finalized an agreement to manage their respective clinical services as an integrated health system. The agreement creates OHSU Partners, a joint management company that will officially become operational on Monday, Nov. 16.
Reports of “super responders” – patients who do exceptionally well on a cancer treatment –may be driving unfounded assumptions about the effectiveness of the drugs involved, researchers caution.
Bay Area Hospital and the OHSU Knight Cancer Institute have agreed to launch the first site of the newly formed OHSU Knight Cancer Network at the Bay Area Cancer Center in Coos Bay, Oregon.
While most new cancer drugs afford modest benefits, approved drugs or those in development may be heralded as “game changers” or “breakthroughs” in the lay press
Oregon Health & Science University today released an iPhone app designed to advance melanoma research by giving users the ability to accurately measure and monitor moles, and contribute photos of how their potential trouble spots evolve over time.
Immunovia AB and the Knight Cancer Institute at Oregon Health & Science University (OHSU) formed a collaboration to confirm, validate and commercialize a blood test for the early diagnosis of pancreatic cancer. The test called IMMray™ PanCan-d analyses a patient’s immune system for early signs of disease. The collaboration will also enable researchers to explore biomarkers for a number of other cancer types.